Login / Signup

Evolution: IMiDs to PPMs, revolution in DLBCL?

Grzegorz S Nowakowski
Published in: Blood (2015)
In this issue of Blood, Hagner et al provide preclinical evidence that CC-122 might be active in both major molecular subtypes of diffuse large B-cell lymphoma (DLBCL).
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • cell therapy
  • single molecule
  • mesenchymal stem cells